Related by context. All words. (Click for frequent words.) 72 ADHD 70 RLS symptoms 67 depressive symptoms 67 daytime sleepiness 66 attention-deficit/hyperactivity disorder ADHD 66 daytime alertness 66 attention-deficit/hyperactivity disorder 65 CONCERTA ® 65 stimulant medications 64 psychotic symptoms 63 symptom severity 63 montelukast 62 asthma exacerbations 62 GERD symptoms 62 depressive symptom 62 psychosocial functioning 62 Attention-Deficit/Hyperactivity Disorder ADHD 61 citalopram 61 oxcarbazepine 61 adenotonsillectomy 61 IBS symptoms 61 nighttime awakenings 61 cognitive functioning 61 inattention hyperactivity 61 neuropsychiatric symptoms 61 cognitive deficits 61 impulsivity 60 somatic symptoms 60 lamotrigine 60 major depressive disorder 60 cognitive function 60 pramipexole 60 disorder ADHD 60 sertraline 60 donepezil 60 acamprosate 60 reflux symptoms 60 HbA1c levels 60 atomoxetine 59 aripiprazole 59 depressive episodes 59 Focalin XR 59 hyperactivity inattention 59 nasal allergy symptoms 59 rotigotine 59 guanfacine 59 blood Phe levels 59 daytime drowsiness 59 fluoxetine 59 stimulant medication 59 valproate 59 depressive disorders 59 fluoxetine Prozac 59 generalized anxiety disorder GAD 59 habitual snoring 59 succimer 58 enuresis 58 suicidality 58 ramelteon 58 SRBD 58 hypersomnia 58 atopic eczema 58 psychostimulants 58 depressive symptomatology 58 tic disorders 58 methylphenidate 58 mood disorders 58 pregabalin 58 juvenile idiopathic arthritis JIA 58 ropinirole 58 rhinoconjunctivitis 57 febrile seizures 57 neurocognitive 57 PMS symptoms 57 euthymic patients 57 dysthymia 57 overactive bladder symptoms 57 salivary cortisol 57 adrenal function 57 hyperactivity impulsivity 57 COPD exacerbations 57 bipolar depression 57 risperidone 57 Hyperactivity Disorder 57 nocturnal enuresis 57 quetiapine 57 teriflunomide 57 T1DM 57 cognitive stimulation 57 attention-deficit/hyperactivity 57 venlafaxine XR 57 depressive relapse 57 migraineurs 57 OAB symptoms 57 atopic 57 clomipramine 57 Antidepressant medications 57 antidepressant therapy 57 solifenacin 57 febrile seizure 57 antidepressant sertraline 57 akathisia 57 etanercept 57 Cognitive behavioral therapy 57 CPAP adherence 57 bipolar illness 56 Major Depressive Disorder 56 hippocampal volume 56 neurocognitive functioning 56 MMSE scores 56 comorbid disorders 56 prescribed Ritalin 56 chronic insomnia 56 paroxetine 56 A1C levels 56 gout flares 56 sleepiness 56 antihypertensive therapy 56 sleep disturbances 56 subclinical hypothyroidism 56 sedating antihistamine 56 molindone 56 interpersonal psychotherapy 56 emotional lability 56 idiopathic Parkinson disease 56 exacerbations 56 euthymic 56 zonisamide 56 dyskinesia 56 cognitive impairment 56 Methylphenidate 56 venlafaxine Effexor 56 pediatric bipolar disorder 56 prodromal symptoms 56 alexithymia 56 hyperactive impulsive 56 cognition 56 methylphenidate Ritalin 56 comorbid depression 56 risperidone Risperdal 56 HAM D# 56 neuropsychological deficits 56 cognitive behavioral therapy 56 generalized seizures 56 adalimumab 56 rTMS 56 psychosocial variables 56 bipolar disorders 56 sleep disordered breathing 56 extrapyramidal symptoms 56 PGTC seizures 56 nasal allergies 56 ADD ADHD 55 levetiracetam 55 Duloxetine 55 urinary symptoms 55 behavioral interventions 55 Topiramate 55 non aspirin NSAIDs 55 L DOPA 55 Anxiety disorders 55 schizophrenia 55 neurocognitive function 55 BPH symptoms 55 vasomotor symptoms 55 autistic traits 55 eszopiclone 55 VUR 55 hyperactivity 55 guanfacine extended release 55 atypical antipsychotic medications 55 nighttime heartburn 55 pyridostigmine 55 nondepressed 55 SGS# 55 INVEGA R 55 HRQL 55 neuroleptics 55 recurrent abdominal pain 55 suicidal behaviors 55 imipramine 55 impulsive behaviors 55 antidepressant medication 55 unipolar depression 55 paroxetine Paxil 55 lipid parameters 55 incontinence episodes 55 Hyperactivity 55 untreated psychosis 55 HRQOL 55 Attention-Deficit/Hyperactivity Disorder 55 divalproex sodium 55 bulimia nervosa 55 divalproex 55 desvenlafaxine succinate 55 Depressive symptoms 55 ziprasidone 55 cortisol secretion 55 psychotic disorders 55 INVEGA 55 neurodevelopmental outcome 55 neuroleptic 55 OROS MPH 55 pharmacologic treatments 55 distractibility 55 antihypertensive medications 55 tiotropium 55 oxycodone CR 55 CONCERTA 55 excessive sleepiness 55 serum cholesterol 55 prolactin levels 55 disulfiram 55 uncontrolled asthma 55 baseline HbA1c 55 EFFEXOR XR 55 salicylates 55 anxiety disorders 55 escitalopram 55 comorbid ADHD 55 dietary supplementation 55 callous unemotional traits 54 AGILECT R 54 hypoglycemic episodes 54 levodopa therapy 54 asthmatic symptoms 54 cognitive behavioral 54 improves glycemic 54 APTIVUS r 54 tegaserod 54 ethosuximide 54 actigraphy 54 GERD 54 dyskinesias 54 epilepsy 54 juvenile idiopathic arthritis 54 lacosamide 54 hemoglobin A1c HbA1c 54 topiramate 54 FAMPYRA 54 ADHD medications 54 impulsivity characteristic 54 atypical neuroleptics 54 migraine sufferers 54 intermittent dosing 54 MBCT 54 serum cortisol 54 HbA 1c 54 Attention Deficit Hyperactive Disorder 54 nicotine dependence 54 nortriptyline 54 ADHD RS 54 ADHD Attention Deficit 54 anticonvulsants 54 ABILIFY 54 venlafaxine 54 LUNESTA 54 RLS 54 ADHD stimulant 54 psychiatric disorders 54 hypomanic symptoms 54 prodrug stimulant 54 intermittent exotropia 54 NPH insulin 54 non affective psychosis 54 cardiometabolic risk 54 psychotic illness 54 bosentan 54 asthma exacerbation 54 citalopram Celexa 54 sertraline Zoloft 54 SSRI citalopram 54 glycemia 54 virological response 54 bipolar disorder 54 insomnia 54 episodic migraine 54 Abilify aripiprazole 54 psychiatric diagnoses 54 tranylcypromine 54 levodopa 54 Child Behavior Checklist 54 placebo controlled studies 54 poststroke 54 OSAHS 54 daytime naps 54 schizophrenia schizoaffective disorder 54 SNRI 54 UPDRS 54 Endothelial function 54 YMRS 54 rasagiline 54 nonpsychotic 54 oral naltrexone 54 gastrointestinal symptoms 54 transient insomnia 54 PREZISTA r 54 anticonvulsant 54 Attention Deficit Hyperactivity Disorder 54 GH deficiency 54 manic depressive illness 54 glucose lowering 54 hyperphenylalaninemia HPA due 54 #mg doses [002] 53 parasomnias 53 hyperglycemia 53 amblyopia 53 clinically meaningful improvements 53 apneas 53 olanzapine 53 atopy 53 tic severity 53 #mg dose [001] 53 dopamine antagonists 53 INVEGA ® 53 airway inflammation 53 insulin detemir 53 recurrent wheezing 53 DAYTRANA 53 premenstrual dysphoric disorder 53 maladaptive behaviors 53 serotonin reuptake inhibitors 53 A1c levels 53 leukotriene receptor antagonists 53 primary generalized tonic 53 #mg/day [001] 53 psychoeducation 53 psychomotor 53 depressive disorder 53 dietary intakes 53 severe hypoglycemia 53 coadministration 53 affective disorders 53 AZILECT R 53 Cortisol levels 53 Longitudinal studies 53 pentoxifylline 53 generalized tonic clonic seizures 53 TF CBT 53 HRQoL 53 ziconotide 53 dosing frequency 53 NUVIGIL 53 psychotherapies 53 esomeprazole 53 prescribed Adderall 53 antidepressant medications 53 tic disorder 53 anticholinergics 53 antipsychotic 53 suicide attempters 53 eczema 53 apnea hypopnea index 53 N acetylcysteine 53 upper limb spasticity 53 tricyclic antidepressants 53 rivastigmine 53 menstrual pain 53 Chronic insomnia 53 HbA 1c levels 53 clinically meaningful 53 tacrolimus ointment 53 glycosylated hemoglobin HbA1c 53 glucose tolerance 53 arterial stiffness 53 ruboxistaurin 53 dysfunctional voiding 53 serum phosphorus 53 Aripiprazole 53 erosive esophagitis 53 RLAI 53 EDSS scores 53 mecamylamine 53 generalized anxiety disorder 53 perimenopausal women 53 clinically meaningful improvement 53 diabetic neuropathic pain 53 symptoms 53 HPA axis 53 MADRS score 53 ACTEMRA 53 dietary intake 53 Welchol 53 tricyclics 53 dyslipidaemia 53 magnetic stimulation 53 endothelial function 53 haloperidol Haldol 53 cognitive abilities 53 apneic episodes 53 ADCS CGIC 53 tiagabine 53 lipid profiles 53 RISPERDAL ® 53 SAPHRIS 53 Lamotrigine 53 premorbid 53 QoL 53 brain shrinkage 53 nocturnal hypoglycemia 53 COPAXONE R 53 carotid IMT 53 subsyndromal 53 clozapine 52 dopamine agonist 52 STEP BD 52 L dopa 52 Fasudil 52 clinically meaningful reductions 52 melatonin supplements 52 Suicidal ideation 52 safinamide 52 prodrome 52 PLMS 52 glycated hemoglobin levels 52 antiepileptics 52 chronicity 52 frequent awakenings 52 iNO 52 hay fever symptoms 52 tolterodine 52 premenstrual syndrome PMS 52 acute mania 52 airflow obstruction 52 antiepileptic drug 52 Topomax 52 lung function 52 vesicoureteral reflux 52 symptomatology 52 nasal symptoms 52 abnormal lipid 52 elevated creatinine 52 oral corticosteroid 52 armodafinil 52 buspirone 52 manic hypomanic 52 psychodynamic psychotherapy 52 menstrual migraine 52 blood glucose levels 52 externalizing disorders 52 abrupt discontinuation 52 SSRI antidepressants 52 suicidal behavior 52 nocturnal awakenings 52 MAO inhibitors 52 hypoglycemic events 52 PRISTIQ 52 Lactobacillus KW 52 placebo controlled clinical 52 neurocognitive deficits 52 typical antipsychotics 52 canakinumab 52 fluticasone salmeterol 52 exploratory endpoints 52 serum urate 52 MIRAPEX ER 52 lipid levels 52 fasting plasma glucose 52 postprandial glucose 52 gabapentin 52 night wakings 52 cholinergic tone 52 sildenafil Viagra 52 paliperidone 52 adolescents 52 selegiline 52 tiotropium bromide 52 atypical antipsychotic 52 neurodevelopmental 52 dosing interval 52 decrements 52 KAPIDEX 52 Pramipexole 52 cognitive dysfunction 52 fructose diet 52 tasimelteon 52 Parkinson disease PD 52 Irritability 52 Vimpat ® 52 glatiramer acetate 52 Keppra R 52 cardiac toxicity 52 Victoza R 52 partial onset seizures 52 Adalimumab 52 bothersome symptom 52 cortisol levels 52 tocilizumab 52 erectile function 52 mood dysregulation 52 severe hypoglycaemia 52 airway hyperresponsiveness 52 colorectal adenomas 52 poststroke depression 52 serum uric acid 52 delusions hallucinations 52 atopic dermatitis 52 subjective sleepiness 52 Decety 52 subclinical atherosclerosis 52 extrapyramidal disorder 52 serum sodium 52 cholinesterase inhibitors 52 prazosin 52 neurodevelopmental outcomes 52 nonadherence 52 NATRECOR R 52 Bipolar disorder 52 affective disorder 52 quetiapine Seroquel 52 anticholinergic drugs 52 dietary calcium intake 52 proliferative diabetic retinopathy 52 leukotriene receptor antagonist 52 psychiatric comorbidities 52 platelet inhibition 52 Lu AA# 52 rufinamide 52 neuropsychiatric disorder 52 DPNP 52 metabolic parameters 52 fasting insulin 52 HAART regimens 52 timepoints 52 generalized epilepsy 52 IFN beta 52 depressive episode 52 budesonide formoterol 52 desmopressin 52 hypertensives 52 psychopharmacologic 52 tapentadol ER 52 dosage regimens 52 ziprasidone Geodon 52 psychostimulant drugs 52 neurobehavioural 52 neurocognitive impairment 52 parkinsonism 52 caffeine intake 52 neuropsychological functioning 52 hypopneas 52 allergic asthma 52 MMRV vaccine 52 CANCIDAS 52 placebo controlled trials 52 escitalopram Lexapro 52 perceptual reasoning 52 symptom checklist 52 mirtazapine 52 ACIPHEX 52 Interpersonal psychotherapy 52 valproic acid 52 phenytoin 52 Anticonvulsants 52 Teriflunomide 52 cyclic HMB 52 cognitive behavioral therapies 52 Relieve Depression 52 pharmacological interventions 52 bedwetting 52 Atomoxetine 51 intractable epilepsy 51 comorbid 51 tardive dyskinesia 51 antiepileptic drugs AEDs 51 glucocorticoid 51 proteinuria 51 allergy symptoms 51 cognitive 51 repetitive behaviors 51 primidone 51 cognitive impairments 51 inhaled steroids 51 monoamine oxidase inhibitors 51 adhd 51 IBS sufferers 51 irritability 51 selective serotonin reuptake inhibitor 51 treprostinil 51 zolmitriptan 51 antibiotic rifaximin 51 migraines 51 haloperidol 51 mania hypomania 51 cotinine levels 51 shorter telomere length 51 airway responsiveness 51 irritable bowel syndrome IBS 51 dietary interventions 51 psychopharmacological 51 sleep disorders 51 MIRAPEX 51 pramlintide 51 Ropinirole 51 serum IGF 51 Paxil paroxetine 51 Risperidone 51 perceptual distortions 51 Oppositional Defiant Disorder 51 nasal obstruction 51 tricyclic antidepressant 51 systolic BP 51 FeNO 51 perennial allergic rhinitis 51 placebo controlled clinical trials 51 corticosteroid dose 51 intensive statin therapy 51 suicidal ideation 51 Fasting plasma glucose 51 blood phenylalanine Phe 51 antipsychotic medications 51 COPD exacerbation 51 BMI z 51 T2DM 51 hepatic encephalopathy HE 51 hsCRP levels 51 EXJADE 51 daytime somnolence 51 ULORIC 51 diagnosing ADHD 51 systemic corticosteroid 51 psychoactive medication 51 ASDs 51 pharmacological therapy 51 anticholinergic 51 NIH CPSI 51 ginkgo biloba extract 51 elevated triglycerides 51 abstinent alcoholics 51 XR NTX 51 Intuniv 51 gastric acidity 51 inhaled corticosteroid therapy 51 stereotypy 51 Prozac fluoxetine 51 anxiolytic 51 gastrointestinal motility 51 behavioral disinhibition 51 symptomology 51 carbamazepine 51 metformin sulfonylurea 51 #mg/day [002] 51 convergence insufficiency 51 behavioral abnormalities 51 Keppra ® 51 zopiclone 51 status epilepticus 51 efalizumab 51 creatine supplementation 51 hypercholesterolemia 51 inhaled corticosteroids 51 QT intervals 51 antidepressant 51 virologic response 51 overt nephropathy 51 borderline personality disorder 51 neurobehavioral disorder 51 laboratory abnormalities 51 hemoglobin A1c levels 51 dose colchicine 51 Unified Parkinson Disease 51 Toviaz 51 elevated LDL cholesterol 51 KAPVAY ™ 51 analgesic medications 51 dyspnea 51 antipsychotic efficacy 51 Asperger Disorder 51 Restless Legs Syndrome RLS 51 corrected QT interval 51 duloxetine Cymbalta 51 hippocampal volumes 51 CIMZIA ™ 51 recurrent venous thromboembolism 51 Quetiapine 51 SSRI SNRI 51 insulin degludec 51 SSRI antidepressant 51 neurologic disorders 51 MS relapses 51 white matter hyperintensities 51 Epworth Sleepiness Scale 51 acarbose 51 ONGLYZA 51 agomelatine 51 Personality traits 51 bupropion 51 depression irritability 51 antidiabetic medication 51 infantile spasms 51 Rating Scale MADRS 51 urate levels 51 PTSD symptoms 51 antenatal depression 51 Neuropsychiatric Inventory NPI 51 attain statistical significance 51 serum BDNF 51 MAS XR 51 plasma glucose 51 antihypertensive medication 51 FASPS 51 Valdoxan 51 visilizumab 51 bronchopulmonary dysplasia 51 migraine prophylaxis 51 neurodevelopmental disability 51 bronchodilator 51 Zoloft sertraline 51 INVEGA SUSTENNA 51 nonautistic 51 atypicals 51 serum calcium 51 hyperammonemia 51 Chronic ITP 51 inhaled budesonide 51 VAPRISOL 51 dasatinib 51 pressor response 51 arousals 51 relapsing MS 51 Primary IGFD 51 monoamine oxidase inhibitor 51 desvenlafaxine 51 clozapine Clozaril 51 Montgomery Asberg Depression 51 Personal CGM 51 menopausal symptom 51 acute bipolar mania 51 schizophreniform disorder 51 systolic hypertension 51 hematologic toxicity 51 opioid misuse 51 buproprion 51 anhedonia 51 NAbs 51 plasma glucose concentration 51 adiponectin levels 51 hypoglycemia 51 cardiac autonomic 51 RLS sufferers 51 serum vitamin D 51 moderate aerobic exercise 51 calcium supplementation 51 antidepressants SSRIs 50 pharmacokinetic PK profile 50 serum concentrations 50 internalizing behaviors 50 eosinophilic asthma 50 chromium picolinate supplementation 50 MERLIN TIMI 50 knee osteoarthritis OA 50 antioxidant supplementation 50 affective psychosis 50 convergent validity 50 triptans 50 nonpharmacologic 50 ATACAND 50 serotonin norepinephrine reuptake inhibitor 50 alpha amylase 50 MMSE score 50 androgen depletion 50 Obstructive sleep apnea 50 psychopathology 50 CIPN 50 QTc interval 50 Pfizer Geodon 50 magnesium intake 50 internalizing disorders 50 Asperger disorder 50 6R BH4 50 paroxetine sertraline 50 psychiatric comorbidity 50 Bifeprunox 50 subscale scores 50 conventional antipsychotics 50 somatic complaints 50 hemoglobin A1C 50 Attention deficit hyperactivity 50 ketogenic diet 50 LTRA 50 psychophysiological 50 TOPAMAX 50 postpartum mood 50 allergic rhinitis 50 acute gout flares 50 epileptic seizures 50 severe exacerbations 50 serum lipid levels 50 AZILECT 50 ADAS Cog 50 postherpetic neuralgia 50 paricalcitol 50 posttest 50 trazodone 50 hypochondriasis 50 hypercholesterolaemia 50 comorbid anxiety 50 paliperidone ER 50 autism spectrum disorder 50 fasting glucose levels 50 acute otitis media 50 ABILIFY Injection 50 chronic idiopathic urticaria 50 antiepileptic medications 50 transaminase elevations 50 baclofen 50 renal toxicity 50 inhaled corticosteroid 50 habitual snorers 50 salmeterol fluticasone 50 premenstrual symptoms 50 elevated ALT 50 Withdrawal symptoms 50 prehypertension 50 affective psychoses 50 TEAEs 50 neuroleptic drugs 50 acromegalic patients 50 insulin glargine 50 parkinsonian 50 Chronic Migraine 50 Ritalin Adderall 50 antidepressant efficacy 50 QTc 50 Effexor venlafaxine 50 alteplase 50 psychiatric disorder 50 RAS blockers 50 blood Phe 50 bronchodilation 50 Major depressive disorder 50 serum retinol 50 fructose intolerant 50 wakefulness 50 pimozide 50 steroid inhalers 50 metabolic abnormalities 50 prenatal exposures 50 MEVACOR 50 medication adherence 50 virological failure 50 dopaminergic therapy 50 airway constriction 50 serum folate concentrations 50 elevated serum creatinine 50 tardive dyskinesia TD 50 serotonin norepinephrine reuptake inhibitors 50 zafirlukast 50 sustained virologic response 50 psychological distress 50 p = .# [002] 50 plasma glucose levels 50 airway reactivity 50 anakinra 50 potassium sparing diuretics 50 dose titration 50 depression suicidal ideation 50 inflammatory markers 50 fluticasone 50 neuropsychological impairments 50 cilostazol 50 topical calcineurin inhibitors 50 DSM IV diagnosis 50 #q# deletion syndrome 50 Neurodex 50 treatment emergent AEs 50 paliperidone palmitate 50 ski lls 50 attentional 50 serum clusterin levels 50 Mood disorders 50 externalizing behaviors 50 adjunctive ABILIFY 50 nasal symptom 50 Zomig 50 sedative hypnotics 50 tolvaptan 50 excessive daytime sleepiness 50 EDARBI 50 ibuprofen 50 mild cognitive 50 repetitive transcranial magnetic stimulation 50 topical NSAIDs 50 neurobiological disorder 50 hypoglycaemia 50 cardiorespiratory fitness 50 neurological impairment 50 neurotransmitter GABA 50 quetiapine XR 50 colorectal adenoma 50 prucalopride 50 syndromal 50 diabetic gastroparesis 50 Olanzapine 50 SEROQUEL XR 50 bowel polyps 50 Social Phobia 50 exhaled nitric oxide 50 obstructive sleep apnea 50 otitis media 50 hyperglycaemia 50 levetiracetam Keppra 50 anticholinergic medication 50 neuropsychological tests 50 cholinesterase inhibitor 50 chronic heartburn 50 headache nausea dizziness 50 hypomania 50 hydroxychloroquine 50 mg dose 50 Adult ADHD 50 nocturnal hypoglycaemia 50 IELT 50 Autism Spectrum Disorders ASDs 50 candesartan 50 hematological toxicity 50 platelet activation 50 proton pump inhibitor 50 androgen excess 50 FOSRENOL ® 50 comorbid conditions 50 Sleep disturbances 50 Rotigotine 50 allergic sensitization 50 Generalized anxiety disorder 50 Comorbid 50 uric acid levels 50 onset diabetes mellitus 50 symptom exacerbation 50 UPDRS scores 50 Sertraline 50 senicapoc 50 postdose 50 autism spectrum disorders ASDs 50 relapsing remitting multiple sclerosis 50 LATUDA 50 Clonicel 50 reuptake inhibitor 50 stimulant ADHD 50 Tolvaptan 50 comorbid psychiatric 50 Sjögren syndrome 50 subthreshold depression 50 hypomanic episodes 50 amitriptyline 50 HAMD 50 chronic migraine 50 dexmedetomidine 50 Tourette syndrome 50 neuroimaging studies 50 impulsive behavior 50 erection hardness 50 Psoriasis Area 50 telomere length 50 Ritalin 50 diabetes mellitus DM 50 emotional reactivity 50 analgesic effects 50 lipid lowering medications 50 sedentary behaviors 50 SGAs 50 postprandial glycemia 50 recurrent VTE 50 folic acid supplementation 50 potential confounding variables 50 Excessive daytime sleepiness 50 lomitapide 50 NEXIUM 50 verbal apraxia 50 Bosentan 50 impaired cognition 50 Bed wetting 50 PON1 enzyme 50 HAART regimen 50 oral antidiabetes drugs 50 icatibant 50 asthma 49 antiseizure drug 49 neurobehavioral 49 ARICEPT 49 Eltrombopag 49 Fiorinal 49 TNF inhibitor 49 INVEGA ™ 49 flow mediated dilation 49 ataluren 49 HDRS 49 dextromethorphan DM 49 ACTEMRA TM 49 FFNS 49 sodium valproate 49 blepharospasm 49 buprenorphine naloxone 49 myopathy rhabdomyolysis 49 Sleepiness 49 metabolic syndrome MetS 49 flibanserin #mg 49 ROZEREM 49 Restless Legs Syndrome